Article
Emerging role of pharmacogenomics in heart failure.
Current opinion in cardiology - 1 May 2008
McNamara Dennis M
Abstract excerpt
PURPOSE OF REVIEW: The promise of pharmacogenomics is that it will one day result in targeted heart failure therapy that maximizes individual benefit and diminishes risk. Recent reports from the Beta Blocker Evaluation Survival and African American Heart Failure clinical trials provide a roadmap of how this promise may soon be realized. This review will discuss recent investigations of pharmacogenomics in heart...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
